速溶片的市場規模、佔有率和成長分析（按藥物類別、適應症、分銷管道和地區）：產業預測（2025-2032）

2023年全球速溶片市場規模為56億美元，從2024年的61億美元成長到2032年的120.6億美元，預計預測期內（2025-2032年）複合年成長率為8.9。

由於對無需水或咀嚼即可溶解的固態口服劑型的需求不斷增加，速溶錠劑市場正在不斷成長。此創新解決方案適合活躍人士、老年人和吞嚥困難人士，確保在各種環境下都能獲得藥物。口腔溶解藥物傳遞系統的最新進展增強了藥物治療的快速介入、提高的生物有效性和增強的穩定性等能力。使用者友善的製造流程和穩定的劑量使其成為治療需要快速起效的病症的理想選擇，例如暈動病、過敏發作和急性咳嗽。因此，速溶片劑正成為尋求有效且方便的藥物治療的不同人群的重要選擇。

目錄

介紹

• 分析目的
• 市場範圍
• 定義

分析方法

• 資訊採購
• 次要/主要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析

主要市場考慮因素

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術分析
• 監管分析
• 專利分析
• 案例研究

全球速溶片市場規模/複合年成長率：按藥物類別分類（2025-2032）

• 市場概況
• 抗精神病藥物
• 抗癲癇藥
• 中樞神經系統興奮劑
• 抗焦慮藥
• 抗帕金森氏症藥物
• 抗高血壓藥
• 非類固醇消炎劑
• 抗過敏藥
• 質子幫浦抑制劑
• 其他

全球速溶片市場規模與複合年成長率：依適應症分類（2025-2032）

• 市場概況
• 中樞神經系統疾病
• 消化系統疾病
• 中樞神經系統 (CVS) 疾病
• 過敏
• 其他

全球速溶片市場規模/複合年成長率：依分銷管道分類（2025-2032）

• 市場概況
• 醫院藥房
• 零售藥房
• 藥局
• 網路藥房

全球速溶片市場規模/複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• 梯瓦製藥工業股份有限公司（以色列）
• 諾華公司（瑞士）
• 阿斯特捷利康（英國）
• 邁蘭 NV（美國）
• 輝瑞公司（美國）
• 強生服務公司（美國）
• F. Hoffmann-La Roche Ltd.（瑞士）
• 默克公司（美國）
• 博士健康（加拿大）
• 葛蘭素史克公司（英國）
• 太陽製藥工業有限公司（印度）
• 拜耳公司（德國）
• 禮來公司（美國）
• 雷迪博士實驗室有限公司（印度）
• 武田藥品工業株式會社（日本）
• 吉祥製藥有限公司（日本）
• Zydus Lifesciences 有限公司（印度）
• Torrent 製藥有限公司（印度）
• 西普拉有限公司（印度）
• Aurobindo Pharma Ltd.（印度）

結論和建議

Global Fast Melt Tablets Market size was valued at USD 5.6 billion in 2023 and is poised to grow from USD 6.1 billion in 2024 to USD 12.06 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The fast-melting tablet market is experiencing growth due to the increasing demand for solid oral dosage forms that dissolve without the need for water or chewing. This innovative solution caters to active individuals, the elderly, and those with swallowing difficulties, ensuring drug accessibility in various scenarios. Recent advancements in oral-dissolving drug delivery systems have enhanced their capabilities, offering rapid intervention for drug therapy, improved bioavailability, and enhanced stability. Their user-friendly manufacturing process and consistent dosing make them ideal for handling conditions such as motion sickness, allergic attacks, or acute coughing, where a quick onset of action is essential. As a result, fast-dissolving tablets are becoming an essential option for diverse demographics seeking effective and convenient medication solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fast Melt Tablets market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fast Melt Tablets Market Segmental Analysis

Global Fast Melt Tablets Market is segmented by Drug Class, Indication, Distribution channel and region. Based on Drug Class, the market is segmented into Anti-Psychotics, Anti-Epileptics, CNS Stimulants, Anxiolytics, Anti-Parkinsonian Drugs, Anti-Hypertensive, NSAIDS, Anti-Allergy Drugs, Proton Pump Inhibitors and Others. Based on Indication, the market is segmented into CNS Diseases, GI Diseases, CVS Disorders, Allergy and Others. Based on Distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Drug Stores and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fast Melt Tablets Market

The growth of the Global Fast Melt Tablets market is significantly influenced by several factors. Chief among these is the increasing aging population, many of whom struggle with swallowing traditional pills. The heightened focus on product promotion aimed at improving consumer awareness and patient care is also contributing to market dynamics. As patients seek cost-effective solutions that enhance their quality of life, the demand for fast melt tablets continues to rise. Furthermore, the risks associated with choking or asphyxiation from conventional oral solid formulations underscore the necessity for alternatives. Technological advancements have enabled the development of fast melt tablets that dissolve swiftly, often within three minutes, thereby aligning with pharmacopoeia standards and further driving market growth.

Restraints in the Global Fast Melt Tablets Market

One significant constraint impacting the global fast melt tablets market is the difficulty associated with handling these products. Due to their porous and delicately formed structure, fast melt tablets lack robustness and are often created with minimal compression, rendering them fragile and prone to breakage. This vulnerability complicates storage, transportation, and dispensing processes, ultimately hindering market expansion. As a result, manufacturers face challenges in ensuring product integrity, which could lead to increased costs and limitations in distribution. Addressing these handling concerns is essential for overcoming barriers to growth within the fast melt tablets sector.

Market Trends of the Global Fast Melt Tablets Market

The Global Fast Melt Tablets market is experiencing robust growth, primarily fueled by the increasing demand from the geriatric population, who favor these formulations for their convenience and rapid action. Fast melt tablets eliminate first-pass metabolism issues associated with traditional oral medications, enhancing bioavailability and patient adherence. As this demographic seeks efficient self-administration options with fewer side effects, the trend towards fast-dissolving doses is gaining momentum. While technical challenges in formulation exist, ongoing research and development efforts are anticipated to address these hurdles, presenting significant opportunities for market expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Fast Melt Tablets Market Size by Drug Class & CAGR (2025-2032)

• Market Overview
• Anti-Psychotics
• Anti-Epileptics
• CNS Stimulants
• Anxiolytics
• Anti-Parkinsonian Drugs
• Anti-Hypertensive
• NSAIDS
• Anti-Allergy Drugs
• Proton Pump Inhibitors
• Others

Global Fast Melt Tablets Market Size by Indication & CAGR (2025-2032)

• Market Overview
• CNS Diseases
• GI Diseases
• CVS Disorders
• Allergy
• Others

Global Fast Melt Tablets Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

Global Fast Melt Tablets Market Size & CAGR (2025-2032)

• North America (Drug Class, Indication, Distribution channel)
  • US
  • Canada
• Europe (Drug Class, Indication, Distribution channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Class, Indication, Distribution channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Class, Indication, Distribution channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Class, Indication, Distribution channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kissei Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torrent Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations